Signal transduction pathway regulated by genistein and its therapeutic use

Current Signal Transduction Therapy

Volumn 3, Issue 3, 2008, Pages 231-233

  Yoshida, Kenichi ^a  

^a MEIJI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Chemotherapeutics; Genistein; NF kappaB; Oxidative stress; Signal transduction

Indexed keywords

CALCITRIOL; CISPLATIN; CYCLOOXYGENASE 2; CYTARABINE; DOCETAXEL; ERLOTINIB; FLUOROURACIL; GELATINASE B; GEMCITABINE; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOFLAVONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR; ZINC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ENZYME RELEASE; HUMAN; INHIBITION KINETICS; LYMPHOMA CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVIEW; SIGNAL TRANSDUCTION; SOYBEAN;

EID: 54849428540     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436208785699703     Document Type: Review

References (29)

1. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113-31.
2. Si H, Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 2007; 14: 2581-9.
3. Kousidou OC, Tzanakakis GN, Karamanos NK. Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells. Mini Rev Med Chem 2006; 6: 331-7.
4. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007; 18: 427-42.
5. Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 2005; 591: 147-60.
6. Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndiovu N, Boone E, Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gone expression by soy isoflavones does not require estrogenic activity. Cancer Res 2006; 66: 4852-62.
7. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer 2006; 118: 1930-6.
8. Park SS, Kim YN, Jeon YK, et al. Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma. Cancer Chemother Pharmacol 2005; 56: 271-8.
9. Kim EJ, Shin HK, Park JH. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein. J Med Food 2005; 8: 431-8.
10. Shim HY, Park JH, Paik HD. Nah SY, Kim DS, Han YS. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anticancer Drugs 2007; 18: 649-57.
11. Wang X, Clubbs EA, Bomser JA. Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem 2006; 17: 204-10.
12. Lee KW, Lee HJ. The roles of polyphenols in cancer chemoprevention. Biofactors 2006; 26: 105-21.
13. Borrás C, Gambini J, Gómez-Cabrera MC, et al. Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J 2006; 20: 2136-8.
14. Kajta M, Domin H, Grynkiewicz G, Lason W. Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/ glycogen synthase kinase-3beta intracellular signaling pathway. Neurosciasce 2007; 145: 592-604.
15. Pinski J, Wang Q, Quek ML, et al. Genistein-induced neuroendocrine differentiation of prostate cancer cells. Prostate 2006; 66: 1136-43.
16. Sarkar FH, Adsule S, Padhye S, Kulkarni S, Li Y. The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini Rev Med Chem 2006; 6: 401-7.
17. Banerjee S, Zhang Y, Wang Z, et al. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer 2007; 120: 906-17.
18. El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res 2006; 66: 10553-9.
19. El Touny LH, Banerjee PP. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Caromogenesis 2007; 28: 1710-7.
20. Dijsselbloem N, Goriely S, Albarani V, et al. A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J Immunol 2007; 178: 5048-57.
21. Uchiyama S, Yamaguchi M. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J Cell Biochem 2007; 101: 529-42.
22. Swami S, Krishnan AV, Peehl DM, Feldman D. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 2005; 241: 49-61.
23. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 2006; 66: 4816-25.
24. Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005; 332: 433-40.
25. Shen J, Tai YC, Zhou J, et al. Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling. Exp Hematol 2007; 35: 75-83.
26. Vauzour D, Vafeiadou K, Rice-Evans C, Cadenas E, Spencer JP. Inhibition of cellular proliferation by the genistein metabolite 5,7,3′,4′-tetrahydroxyisoflavone is mediated by DNA damage and activation of the ATR signalling pathway. Arch Biochem Biophys 2007; 468: 159-66.
27. Nguyen DT, Hernandez-Montes E, Vauzour D, et al. The intracellular genistein metabolite 5,7,3′,4′-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Free Radic Biol Med 2006; 41: 1225-39.
28. Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman D. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer. J Nutr 2007; 137: 205S-10S.
29. Choueiri TK, Wesolowski R, Mekhail TM. Phenoxodiol: isoflavone analog with antineoplastic activity. Curr Oncol Rep 2006; 8: 104-7.